As shown in Figure 7F, most of the 24 inhibitory ICPs showed positive correlations with RIPOR2 in most of the 30 cancer types considered here, with the exceptions of brain lower grade glioma (LGG), GBM, PCPG, uterine carcinosarcoma (UCS), and uveal melanoma (UVM). This evidence concerns the gene RIPOR2 and glioblastoma.